Tango Therapeutics Inc (TNGX) returns
Tango Therapeutics returns over 5 years
$1,000 invested in Tango Therapeutics five years ago was worth $1,769 at the close on October 30, 2026, with dividends reinvested: an average return of 12.1% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -8.9% | — | $910.62 | -0.9% |
| 3 months | -17.6% | — | $824.08 | +2.1% |
| Year to date | +156.4% | — | $2,564 | +11.7% |
| 1 year | +185.1% | — | $2,851 | +12.4% |
| 3 years | +173.1% | +39.8% | $2,731 | +88.5% |
| 5 years | +76.9% | +12.1% | $1,769 | +76.0% |
Tango Therapeutics return by calendar year
| Year | TNGX | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +156.4% | +11.7% | +144.7% |
| 2025 | +186.7% | +17.7% | +169.0% |
| 2024 | -68.8% | +24.9% | -93.7% |
| 2023 | +36.6% | +26.2% | +10.4% |
| 2022 | -33.7% | -18.2% | -15.6% |
| 2021 | -4.4% | +28.7% | -33.1% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: TNGX financials
No forecast, no recommendation. This page describes Tango Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.